Regeneron's product recalls
3 official recall notices between May 2024 and Aug 2026 were matched to Regeneron and brands it owned at the time, including Eylea and Libtayo.
Each notice concerns the specific products, sizes and lot codes it names. A recall does not mean that other Regeneron products are affected, and a count of notices is not a measure of safety: one incident can produce a notice for every pack size.
Covers only notices from the U.S. Food and Drug Administration enforcement reports (openFDA), USDA Food Safety and Inspection Service recalls, UK Food Standards Agency food alerts and U.S. Consumer Product Safety Commission recalls that could be matched to Regeneron: the recalling firm must be Regeneron, a parent or a subsidiary, and for a brand the brand name must appear in the product description. Method.
2026 (1)
2024 (2)
| Date | Product | Brand | Recalling firm | Reason given | Source |
|---|---|---|---|---|---|
| EYLEA, (aflibercept) Injection, For Intravitreal injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Glass Syringe, Rx only, Manufactured… | Eylea | Regeneron Pharmaceuticals Inc | Lack of Assurance of Sterility: Complaints of syringe breakage Class II | FDA | |
| EYLEA, (aflibercept) Injection, 2 mg (0.05mL of a 40mg/mL solution), Single-dose Pre-filled Syringe, Rx only, Manufactured by: Regeneron Pharmaceuticals,… | Eylea | Regeneron Pharmaceuticals Inc | Lack of Assurance of Sterility: Complaints of syringe breakage Class II | FDA |
Product descriptions and reasons are shortened from the regulators' own text; the linked notice is the authoritative record. See all matched recalls, or report a wrong match through the corrections page.